Skip to main content

Table 3 Prescribed treatment at discharge by quartiles of RDW

From: Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease

 

Group I

Group II

Group III

Group IV

P value

N = 607

N = 574

N = 663

N = 706

 

<13.1%

13.1 ≥ and <13.6%

13.6% ≥ and <14.1%

≥14.1%

 

Aspirin

601 (99.0)

569 (99.1)

658 (99.2)

693 (98.2)

0.21

Clopidogrel/Thienopiridines

607 (100)

572 (99.7)

658 (99.2)

699 (99.0)

0.25

ACE-I/ARB

585 (96.4)

539 (93.9)

622 (93.8)

641 (90.8)

0.0006

Beta-blockers

581 (95.7)

555 (96.7)

630 (95.0)

671 (95.0)

0.44

Calcium channel blockers

106 (17.5)

82 (14.3)

100 (15.1)

112 (15.9)

0.47

Diuretics

203 (33.4)

194 (33.8)

229 (34.5)

315 (44.6)

<0.0001

Nitrates

121 (19.9)

166 (28.9)

223 (33.6)

233 (33.0)

<0.0001

VKA

23 (3.8)

32 (5.6)

47 (7.1)

83 (11.8)

<0.0001

  1. ACE-I – angiotensin converting enzyme inhibitors, ARB – angiotensin receptor blockers, VKA – vitamin K antagonists.